Home688185 • SHA
add
Cansino Biologics Inc
Previous close
¥58.75
Day range
¥57.90 - ¥59.40
Year range
¥37.12 - ¥75.00
Market cap
10.14B CNY
Avg Volume
1.37M
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 263.65M | 76.09% |
Operating expense | 191.08M | 2.24% |
Net income | 2.96M | 102.06% |
Net profit margin | 1.12 | 101.17% |
Earnings per share | — | — |
EBITDA | 92.06M | -63.96% |
Effective tax rate | 15.12% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.28B | -24.39% |
Total assets | 7.99B | -16.87% |
Total liabilities | 2.93B | -23.25% |
Total equity | 5.06B | — |
Shares outstanding | 246.04M | — |
Price to book | 2.85 | — |
Return on assets | 0.99% | — |
Return on capital | 1.11% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 2.96M | 102.06% |
Cash from operations | -73.17M | -532.37% |
Cash from investing | -646.29M | -376.07% |
Cash from financing | -119.60M | -220.44% |
Net change in cash | -852.33M | -2,478.72% |
Free cash flow | -302.81M | -1,465.00% |
About
CanSino Biologics, often abbreviated as CanSinoBIO, is a Chinese vaccine company. Wikipedia
CEO
Founded
Jan 13, 2009
Website
Employees
1,149
